References
- Annual statistical report on psychotropic substances (29th edition), International Narcotics Control Board. (2018). Retrieved from https://www.incb.org/documents/Psychotropics/greenlist/Green_list_ENG_V18-02416.pdf
- Brown, G. R. (1985). Stadol Dependence: Another Case. JAMA, 254(7), 910. doi:10.1001/jama.1985.03360070048016
- Drugs and cosmetics (2nd Amendment) Rules. (2006). Gazette of India (extraordinary) Part-II, section 3, sub-section (i) vide G.S.R. 160(E). Retrieved from https://web.archive.org/web/20070221055138/http://drugscontrol.org/Schedule_H.pdf
- Evans, W. S., Bowen, J. N., Giordano, F. L., & Clark, B. (1985). A Case of Stadol Dependence. JAMA, 253(15), 2191–2192. doi:10.1001/jama.1985.03350390033007
- Expert Committee on Drug Dependence, World Health Organization. (2006). Retrieved from http://www.who.int/medicines/areas/quality_safety/4.1ButhorphanolCritReview.pdf
- Horan, P., & Ho, I. K. (1991). The physical dependence liability of butorphanol: A comparative study with morphine. European Journal of Pharmacology, 203(3), 387–391. doi:10.1016/0014-2999(91)90895-W
- Merlo, L. J., & Gold, M. S. (2008). Prescription opioid abuse and dependence among physicians: Hypotheses and treatment. Harvard Review of Psychiatry, 16(3), 181–194. doi:10.1080/10673220802160316
- Narcotic Drugs and Psychotropic Substances Act, (1985). (n.d.)". Retrieved from https://dor.gov.in/sites/default/files/Narcotic-Drugs-and-Psychotropic-Substances-Act-1985.pdf
- Shah, B., Gupta, R., Sarkar, S., & Balhara, Y. P. S. (2018). Injection Butorphanol dependence: A case report. Asian Journal of Psychiatry. doi:10.1016/j.ajp.2018.05.008